IMCD N.V. has unveiled its new Mexico headquarters located in the Torre Polanco development in Mexico City. Designed to adapt to the company’s rapidly expanding multi-industry business, the new IMCD México headquarters reflects its investment in its people and the budding partnerships with preeminent global suppliers seeking to develop their business in this key Latin America market.

 

“I am very pleased to begin the next chapter of IMCD México’s growth story with the grand opening of our new headquarters,” said Miguel Ruiseñor, Managing Director, IMCD México. “Our modern workplace was designed to foster growth and cultivate partnerships as we aim to create a world of opportunity for our emerging market in Mexico.”

 

The 810 m² headquarters is conveniently located in a renowned business district in Polanco, Mexico City, and was strategically selected to continually attract top talent for the company’s future growth. It will be a centralized hub for the company’s digitalisation initiatives, formulatory capabilities and business operations. The Torre Polanco building where IMCD México now operates is LEED Gold certified, reflecting IMCD’s global operational goals for sustainable growth and improved environmental impact.  

 

Relatively new to the country upon its market entry through the acquisition of DCS Pharma in 2019 and its rebranding to IMCD México in April 2020, IMCD México is now comprised of 106 employees following organic growth and the additional acquisitions of Millikan (2021), Banner Química (2021) and Maquimex (2022). IMCD México’s market-focused team is dedicated to serving the pharmaceuticals, food, nutrition, beauty, personal care, HI&I, water treatment and other industrial markets, with the intent to further enhance its technical and commercial offerings to better serve customers across the country.